Yoshitaka Wakabayashi

Dr. Yoshitaka Wakabayashi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
AYAi Yamamoto
Ai Yamamoto
SNShin Nakayama
Shin Nakayama
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
YYYusuke Yoshino
Yusuke Yoshino
TKTakatoshi Kitazawa
Takatoshi Kitazawa
Pyelonephritis is a common infection at any age. Urine neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker of acute renal failure, is related to pyelonephritis in pediatric patients, although the significance of this urine biomarker in adult patients are not clear. We investigated the relationship between urine NGAL of pyelonephritis and non-pyelonephritis. We prospectively enrolled adult patients who were hospitalized due to pyelonephritis or non-pyelonephritis. Pyelonephritis was diagnosed in patients with fever and bacteriuria, with no any other infection focuses. Non-pyelonephritis was diagnosed in patients who had fever and another infection focus without bacteriuria. Urine samples were collected on days 0, 3 and 7. Urine NGAL levels were measured by ELISA. There were 35 patients in the pyelonephritis group and 19 patients in the non-pyelonephritis group. Urine NGAL level were significantly higher in the pyelonephritis group than the non-pyelonephritis group on day 0 (median 302 ng/mL vs 25 ng/mL, p = 0.006). The area under the receiver operating characteristic curve of NGAL was 0.78 (p = 0.006). Urine NGAL level had a specificity of 66.7% and sensitivity of 87.0% at the cut-off level of 250 ng/mL for diagnosing pyelonephritis. Urine NGAL level at the diagnosis of infection are elevated in adult patients with pyelonephritis, but not in those with non-pyelonephritis. Urine NGAL might be a supportive biomarker for the diagnosis of pyelonephritis.

15 July 2022 in BMC Molecular and Cell Biology
Verified
Journal Article
Open access
PDF file
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
SNShin Nakayama
Shin Nakayama
AYAi Yamamoto
Ai Yamamoto
TKTakatoshi Kitazawa
Takatoshi Kitazawa
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters the host cell by binding to angiotensin-converting enzyme 2 (ACE2) receptors. ACE2 is expressed on human airway epithelial cells. Increased ACE2 expression may be associated with potentially high risk of COVID-19. However, the factors responsible for the regulation of ACE2 expression in human airway epithelial cells are unknown. Furthermore, hyperglycemia is a risk factor for poor disease prognosis. Results: In this study, we investigated the effects of D-glucose on ACE2 mRNA and protein expressions in Calu-3 bronchial submucosal cells. The cells were cultured in minimal essential medium containing different D-glucose concentrations. After 48 and 72 h of high D-glucose (1000 mg/dL) treatment, ACE2 mRNA expressions were significantly increased. ACE2 protein expressions were significantly increased after 24 h of high D-glucose treatment. ACE2 mRNA expression was enhanced by a D-glucose concentration of 550 mg/dL or more after 72 h of treatment. In addition, we investigated the role of glucose transporters (GLUTs) in Calu-3 cells. ACE2 mRNA and protein expressions were suppressed by the GLUT1 inhibitor BAY-876 in high D-glucose-treated Calu-3 cells. GLUT-1 siRNA was also used and ACE2 mRNA expressions were suppressed in high D-glucose-treated Calu-3 cells with GLUT-1 knockdown. Conclusions: This is the first report indicating that high D-glucose levels induced ACE2 expression via GLUT1 in bronchial submucosal cells in vitro. As hyperglycemia can be treated appropriately, these findings could help reduce the risk of worsening of coronavirus disease 2019.

18 July 2022 in Anaerobe
Verified
Journal Article
Closed access
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
SNShin Nakayama
Shin Nakayama
AYAi Yamamoto
Ai Yamamoto
YYYusuke Yoshino
Yusuke Yoshino
SIShinobu Ishigaki
Shinobu Ishigaki
TKTakatoshi Kitazawa
Takatoshi Kitazawa

11 February 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
SKSatoshi Kitaura
Satoshi Kitaura
KOKoh Okamoto
Koh Okamoto
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
YOYuta Okada
Yuta Okada
AOAiko Okazaki
Aiko Okazaki
KMKyoji Moriya
Kyoji Moriya
Mycobacterium haemophilum is a nontuberculous mycobacteria (NTM) with a predilection for skin and soft tissue infection (SSTI) in the immunocompromised host. We report a case of disseminated M haemophilum infection initially presenting as a nonresolving subacute cellulitis of bilateral lower extremities. Genetic sequencing was used for final identification, while a commercially available polymerase chain reaction test returned a false-positive result for Mycobacterium intracellulare. Consequently, we highlight the importance of M haemophilum as a major differential diagnosis of SSTI in the immunocompromised host and the need for careful interpretation of rapid diagnostic tests.

1 February 2018 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
SYShinya Yamamoto
Shinya Yamamoto
MIMahoko Ikeda
Mahoko Ikeda
FFFumie Fujimoto
Fumie Fujimoto
KOKoh Okamoto
Koh Okamoto
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
KMKyoji Moriya
Kyoji Moriya

1 May 2019 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YWYoshitaka Wakabayashi
Yoshitaka Wakabayashi
DJDaisuke Jubishi
Daisuke Jubishi
KOKoh Okamoto
Koh Okamoto
MIMahoko Ikeda
Mahoko Ikeda
KTKeita Tatsuno
Keita Tatsuno
KMKyoji Moriya
Kyoji Moriya